3654 results for «365»
3654 results
PCI for complex left main disease - LIVE Case
23 May 2025 – From EuroPCR 2025
An 82-year-old male patient with a history of STEMI and diagonal PCI (2004) presented with stable angina (CCS 2). CT imaging revealed 2 severe LAD stenoses (at the ostium and mid part), and a severe bifurcation stenosis at the Cx/OM1 confirmed by angiography. A staged PCI...
Welcome to EuroPCR 2025
20 May 2025 – From EuroPCR 2025
Welcome to EuroPCR 2025, the premier event for interventional cardiology innovation and education, where leaders and professionals gather to shape the future of cardiovascular care.
EAPCI Fellowship Grant Awards
21 May 2025 – From EuroPCR 2025
Celebrate the achievements of emerging cardiology leaders with the EAPCI Fellowship Grant Awards session. This presentation highlights the awarded fellows' contributions and the impact of fellowship support on advancing interventional cardiology research and clinical practice.
EuroPCR 2025 Closing Ceremony
23 May 2025 – From EuroPCR 2025
Conclude your conference experience with the EuroPCR 2025 Closing Ceremony, celebrating the achievements, innovations, and advancements presented throughout the event, and setting the stage for future developments in interventional cardiology.
Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award
21 May 2025 – From EuroPCR 2025
Celebrate innovation and research excellence in interventional cardiology with the Jon DeHaan Foundation Award and Michele Pighi Young Investigator Award session. This session highlights groundbreaking work and emerging talent shaping the future of cardiovascular interventions.
Andreas Grüntzig Ethica Award
22 May 2025 – From EuroPCR 2025
Recognize excellence in interventional cardiology with the prestigious Andreas Grüntzig Ethica Award. This session honors outstanding contributions and ethical standards that advance the field and improve patient care worldwide.
EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome
22 May 2025 – From EuroPCR 2025
Mark the 20th anniversary of EuroIntervention with this special annual editorial meeting open to all EuroPCR participants. Reflect on the journal's achievements, discuss future directions, and engage with leaders in interventional cardiology to shape the evolving landscape of cardiovascular research and practice.
Refractory heart failure: combining oral therapy and device is key
21 May 2025 – From EuroPCR 2025
Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.
Transcatheter management of failed THV - LIVE case
Recommended by PCR
09 Feb 2025 – From PCR Tokyo Valves 2025
An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...
Highlights of science and education in cardiovascular interventional medicine in 2025
22 Dec 2025
Dear Colleagues, dear PCR Companions,
As we welcome a New Year, it is the perfect time to reflect on what we achieved together over the past year - both as a celebration of our collective success and as motivation to continue improving in the year ahead.
2025 was...
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation
04 Nov 2024
Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.
Also watch the interview with Susheel K. Kodali
Author
